The Psychological Impact of COVID-19 among a Sample of Italian Adults with High-Functioning Autism Spectrum Disorder: A Follow-Up Study.

Autism Spectrum Disorder COVID-19 PTSD SARS-CoV-2 anxiety depression lockdown stress

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
22 Apr 2022
Historique:
received: 29 03 2022
revised: 08 04 2022
accepted: 21 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

The strict lockdowns imposed to contain the COVID-19 pandemic brought an increase in levels of stress, anxiety, and depression in the general population. However, in a previous study, our group found that individuals with High-Functioning Autism Spectrum Disorders (HF-ASD) reported an increase in their psychological wellbeing and a decrease in their daily tiredness, in relation to the social distancing measures imposed during the first Italian lockdown (between March and May 2020). In this follow-up study, conducted during the "second wave" of COVID-19, we included the same group of individuals with HF-ASD and evaluated their levels of stress, anxiety, depression, PTSD-related symptoms, tiredness, and perceived wellbeing; moreover, we compared our results to the ones we obtained during the first lockdown on the same population. We found that individuals with HF-ASD experienced higher levels of the aforementioned psychiatric symptoms during the second lockdown, with respect to the first one. These levels positively correlated with their scores at the Autism Quotient subscale Attention Switching: hence, we speculated that these symptoms might be due not only to the prolonging of the social distancing measures, but also to the uncertainty that HF-ASD participants started experiencing at the end of the first lockdown.

Identifiants

pubmed: 35627919
pii: healthcare10050782
doi: 10.3390/healthcare10050782
pmc: PMC9140581
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Neurosci. 2022 Jan;95:27-30
pubmed: 34929647
Front Psychiatry. 2020 Dec 22;11:561345
pubmed: 33414728
Psychiatry Clin Neurosci. 2007 Feb;61(1):99-104
pubmed: 17239046
Psychiatry Res. 2014 Dec 15;220(1-2):705-7
pubmed: 25200187
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Brain Behav Immun. 2020 Aug;88:916-919
pubmed: 32169498
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
J Autism Dev Disord. 1988 Dec;18(4):601-15
pubmed: 3215886
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657
J Autism Dev Disord. 2011 Aug;41(8):1076-89
pubmed: 21086033
Mol Autism. 2021 Mar 3;12(1):21
pubmed: 33658046
J Autism Dev Disord. 2014 Oct;44(10):2440-9
pubmed: 24715257
J Autism Dev Disord. 2023 Jan;53(1):319-331
pubmed: 35076831
J Autism Dev Disord. 2014 Aug;44(8):1996-2012
pubmed: 24590409
Res Dev Disabil. 2021 Jan;108:103822
pubmed: 33271447
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
Medsurg Nurs. 2012 Sep-Oct;21(5):321-2
pubmed: 23243796
J Affect Disord. 2021 Mar 1;282:695-696
pubmed: 33445094
Brain Behav Immun. 2020 Jul;87:75-79
pubmed: 32325098

Auteurs

Veronica Nisticò (V)

Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20142 Milano, Italy.
"Aldo Ravelli" Research Center for Neurotechnology and Experimental Brain Therapeutics, Università degli Studi di Milano, 20142 Milano, Italy.
Dipartimento di Psicologia, Università degli Studi di Milano-Bicocca, 20126 Milano, Italy.

Giulia Fior (G)

Unità di Psichiatria 52, ASST Santi Paolo e Carlo, Presidio San Paolo, 20142 Milano, Italy.

Raffaella Faggioli (R)

Unità di Psichiatria 52, ASST Santi Paolo e Carlo, Presidio San Paolo, 20142 Milano, Italy.

Alberto Priori (A)

Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20142 Milano, Italy.
"Aldo Ravelli" Research Center for Neurotechnology and Experimental Brain Therapeutics, Università degli Studi di Milano, 20142 Milano, Italy.
III Clinica Neurologica, ASST Santi Paolo e Carlo, Presidio San Paolo, 20142 Milano, Italy.

Orsola Gambini (O)

Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20142 Milano, Italy.
"Aldo Ravelli" Research Center for Neurotechnology and Experimental Brain Therapeutics, Università degli Studi di Milano, 20142 Milano, Italy.
Unità di Psichiatria 52, ASST Santi Paolo e Carlo, Presidio San Paolo, 20142 Milano, Italy.

Benedetta Demartini (B)

Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20142 Milano, Italy.
"Aldo Ravelli" Research Center for Neurotechnology and Experimental Brain Therapeutics, Università degli Studi di Milano, 20142 Milano, Italy.
Unità di Psichiatria 52, ASST Santi Paolo e Carlo, Presidio San Paolo, 20142 Milano, Italy.

Classifications MeSH